← Leaderboards
Karl J Okolotowicz
Chemregen Inc
$80,185
Attributed
$240,555
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$240,555 · 1
By mechanism
R41$240,555 · 1
Top collaborators
- John R Cashman1 shared
- Sigeng Chen1 shared
Most similar at Chemregen Inc
Same institution · by research overlap
- Sigeng Chen$80,185
- Jorge E. Gomez-Galeno$271,318
- Christina A Jamieson$71,550
Others in their field
Top investigators on “Adverse Effects”
- James Dennis Neaton · Northwestern University$203,539,316
- John M Lachin · George Washington University$139,991,329
- Elizabeth A Thom · George Washington University$126,101,581
- David M Nathan · Massachusetts Institute Of Technology$120,651,895
- Constance Ann Benson · University Of California, San Diego$114,806,215
- Wafaa M. El-Sadr · Columbia University Health Sciences$102,102,044
Research focus
Adverse EffectsAnimal ModelApoptosisBaseBinding (Molecular Function)BioavailableCancer BiologyCancer CellCancer Cell LineCancer CenterCancer EtiologyCell LineCell ModelCell ProliferationCellsCell SurvivalCessation Of LifeColonCombination Drug TherapyControl AnimalDiagnosisDna BiosynthesisDoseAcute